Water Systems for Peptide Manufacturing: PW vs. WFI¶
Introduction¶
Water is the most critical raw material in peptide manufacturing. It is used as a solvent, process intermediate, cleaning agent, and formulation excipient. The quality of water directly impacts product purity, stability, and patient safety. This guide covers the types of pharmaceutical water used in peptide manufacturing, their specifications, production methods, and quality monitoring requirements.
Water Quality Tiers in Pharmaceutical Manufacturing¶
Purified Water (PW)¶
Purified Water (PW) is produced by distillation, deionization, reverse osmosis, or other suitable processes. It meets compendial specifications for purified water but does not have a requirement for bacterial endotoxin control.
Common uses in peptide facilities: - Non-critical cleaning (intermediate rinses) - Feed water to WFI systems - Buffer preparation for purification chromatography - Water for bulk peptide precipitation - Cooling and utility applications
Not suitable for: - Final rinse of product-contact equipment - Lyophilized product formulation - Parenteral (injectable) peptide products
Water for Injection (WFI)¶
WFI is the highest quality pharmaceutical water, meeting stringent endotoxin and microbial limits. It is produced by distillation or by reverse osmosis combined with ultrafiltration.
Common uses in peptide facilities: - Final rinse of product-contact equipment - Formulation of injectable peptide products - Lyophilization reconstitution - Cleaning of aseptic processing areas - Critical chromatography buffers for GMP final purification
Regulatory note: The European Pharmacopoeia (Ph. Eur.) only permits distillation for WFI production, while USP allows both distillation and non-distillation methods (RO + UF).
Pharmacopeial Water Specifications¶
| Parameter | PW (USP/Ph. Eur./JP) | WFI (USP) | WFI (Ph. Eur.) | WFI (JP) |
|---|---|---|---|---|
| Conductivity (25 °C) | ≤1.3 µS/cm | ≤1.3 µS/cm | ≤1.1 µS/cm | ≤1.3 µS/cm |
| TOC (Total Organic Carbon) | ≤500 ppb | ≤500 ppb | ≤500 ppb | ≤500 ppb |
| Endotoxins | Not specified | ≤0.25 EU/mL | ≤0.25 EU/mL | ≤0.25 EU/mL |
| Microbial count (action limit) | ≤100 CFU/mL | ≤10 CFU/100 mL | ≤10 CFU/100 mL | ≤10 CFU/100 mL |
| Nitrates | ≤0.2 ppm | ≤0.2 ppm | ≤0.2 ppm | ≤0.2 ppm |
| Heavy metals | ≤0.1 ppm | ≤0.1 ppm | ≤0.1 ppm | ≤0.1 ppm |
| Aluminum (for dialysis) | N/A | ≤10 ppb | ≤10 ppb | ≤10 ppb |
| Chlorides | ≤0.5 ppm | ≤0.5 ppm | ≤0.5 ppm | ≤0.5 ppm |
| Sulfates | ≤1.0 ppm | ≤1.0 ppm | ≤1.0 ppm | ≤1.0 ppm |
| Ammonia | ≤0.2 ppm | ≤0.2 ppm | ≤0.2 ppm | ≤0.2 ppm |
| pH | 5.0–7.0 | 5.0–7.0 | 5.0–7.0 | 5.0–7.0 |
Water System Components¶
Production¶
| System | Process | Output Quality | Energy Cost | Efficiency |
|---|---|---|---|---|
| RO (Reverse Osmosis) | Pressure-driven membrane filtration | ≤2 µS/cm (single pass) | Moderate | 50–75% recovery |
| EDI (Electrodeionization) | Continuous deionization with electrical regeneration | ≤0.1 µS/cm | Low | >95% recovery |
| RO + CDI (Continuous Deionization) | Two-stage RO + EDI | ≤0.1 µS/cm | Low | Premium quality |
| Vapor Compression Distillation | Thermal evaporation and condensation | ≤1.0 µS/cm | High | 80–95% recovery |
| Multiple Effect Distillation | Multi-stage thermal distillation | ≤1.0 µS/cm | Very high | 70–85% recovery |
| RO + UF | RO followed by ultrafiltration | WFI-compatible (USP only) | Moderate | 60–75% recovery |
Distribution¶
- PW loops: Ambient or temperature-controlled (20–25 °C), continuous circulation at 1–2 m/s
- WFI loops: Hot (65–80 °C) or ambient with periodic thermal sanitization
- Pipe material: 316L stainless steel, electropolished internal surfaces, orbital welded joints
- Minimum slope: 1% toward drain points
- No dead legs: Maximum 6× pipe diameter for sample points
Quality Monitoring Program¶
| Parameter | PW Monitoring | WFI Monitoring | Frequency |
|---|---|---|---|
| Conductivity | Online (continuous) | Online (continuous) | Continuous |
| TOC | Online (continuous) | Online (continuous) | Continuous |
| Flow rate | Online | Online | Continuous |
| Temperature | Online | Online | Continuous |
| Microbial sampling | Weekly (at each use point) | Weekly | Weekly |
| Endotoxin sampling | Not required | Monthly | Monthly |
| Total bioburden | Monthly | Monthly | Monthly |
Action and Alert Limits¶
| Parameter | Alert Limit | Action Limit |
|---|---|---|
| PW conductivity (25 °C) | 1.0 µS/cm | 1.3 µS/cm |
| WFI conductivity (25 °C) | 0.8 µS/cm | 1.1 µS/cm |
| PW TOC | 300 ppb | 500 ppb |
| WFI TOC | 250 ppb | 500 ppb |
| PW microbial (CFU/mL) | 50 CFU/mL | 100 CFU/mL |
| WFI microbial (CFU/100 mL) | 5 CFU/100 mL | 10 CFU/100 mL |
| WFI endotoxin (EU/mL) | 0.10 EU/mL | 0.25 EU/mL |
Sanitization Methods¶
| Method | Temperature | Duration | Application | Compatibility |
|---|---|---|---|---|
| Hot water sanitization | 80–85 °C | 1–2 hours | PW and WFI loops | 316L SS only |
| Steam sanitization | 121 °C | 30 min | WFI loops | Requires steam-rated components |
| Ozone | 0.05–0.5 ppm continuous | Continuous | PW loops | Requires UV destruction before use |
| Chemical (NaOH) | 0.5–1.0 M NaOH | 1–2 hours | PW loops | Requires extensive rinsing |
| UV (254 nm) | N/A | Continuous | Microbial control | No residual; limited to flow rate |
Impact on Peptide Manufacturing¶
Why Water Quality Matters¶
| Water Quality Issue | Impact on Peptide Product |
|---|---|
| High TOC (>500 ppb) | Organic impurities detected in final product; failed release testing |
| Endotoxin contamination | Pyrogenic response in injectable products; batch rejection |
| Microbial presence | Biofilm in purification columns; degraded peptide during processing |
| Silicate / heavy metals | Chelation with peptide; altered bioactivity; color changes |
| Chloride / sulfates | Counter-ion interference; salt formation |
| pH excursions | Hydrolysis of sensitive side chains; Met/Trp oxidation |
Critical Water Use Points in Peptide Processing¶
| Process Step | Water Grade Required | Why |
|---|---|---|
| Resin washing (SPPS) | PW | Residual DMF removal |
| Preparative HPLC buffers | PW or WFI | TOC >500 ppb introduces ghost peaks |
| Final RP-HPLC purification | WFI | Product directly collected; endotoxin control |
| Lyophilization reconstitution | WFI | Final formulation step |
| Equipment cleaning final rinse | WFI | Prevents endotoxin carryover to next batch |
| Cleanroom cleaning | PW | Environmental control |
Best Practices¶
- Never co-mingle PW and WFI systems — keep distribution loops completely separate
- Monitor continuously — online conductivity and TOC provide real-time quality assurance
- Maintain flow velocity — ≥1.5 m/s in loops prevents biofilm formation
- Sanitize on schedule — do not wait for microbial action limits to trigger corrective actions
- Sample representatively — sample at use points, not just the loop return
- Trend all data — gradual increases in conductivity or TOC often precede excursions
- Use dedicated sample ports — avoid valves or tees that create dead legs
🔗 Related: Cleanroom Classification | Chromatography Skid Systems | Laboratory-Scale Reactors | HPLC Method Validation